Tarsons Products Ltd
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]
- Market Cap ₹ 1,638 Cr.
- Current Price ₹ 307
- High / Low ₹ 465 / 280
- Stock P/E 59.5
- Book Value ₹ 118
- Dividend Yield 0.65 %
- ROCE 6.91 %
- ROE 4.75 %
- Face Value ₹ 2.00
Pros
Cons
- Stock is trading at 2.60 times its book value
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|
229 | 301 | 296 | 392 | 399 | |
125 | 148 | 196 | 282 | 282 | |
Operating Profit | 103 | 153 | 100 | 111 | 117 |
OPM % | 45% | 51% | 34% | 28% | 29% |
5 | 8 | 11 | 16 | 16 | |
Interest | 3 | 4 | 10 | 20 | 20 |
Depreciation | 14 | 22 | 40 | 62 | 71 |
Profit before tax | 92 | 135 | 61 | 45 | 42 |
Tax % | 25% | 25% | 30% | 34% | |
69 | 101 | 43 | 30 | 28 | |
EPS in Rs | 3,583.25 | 18.92 | 8.01 | 5.60 | 5.17 |
Dividend Payout % | 0% | 0% | 25% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 9% |
TTM: | 32% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -34% |
TTM: | -31% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -28% |
1 Year: | -30% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Equity Capital | 0.19 | 11 | 11 | 11 |
Reserves | 244 | 479 | 602 | 620 |
34 | 22 | 269 | 339 | |
18 | 33 | 90 | 111 | |
Total Liabilities | 296 | 544 | 972 | 1,080 |
120 | 189 | 336 | 536 | |
CWIP | 22 | 32 | 267 | 233 |
Investments | 0 | 0 | 0 | 0 |
153 | 323 | 369 | 311 | |
Total Assets | 296 | 544 | 972 | 1,080 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
68 | 83 | 103 | 114 | |
-64 | -138 | -285 | -145 | |
-27 | 130 | 136 | 39 | |
Net Cash Flow | -23 | 75 | -47 | 8 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Debtor Days | 75 | 79 | 96 | 74 |
Inventory Days | 277 | 478 | 572 | 355 |
Days Payable | 35 | 75 | 65 | 44 |
Cash Conversion Cycle | 317 | 482 | 602 | 385 |
Working Capital Days | 108 | 150 | -1 | 38 |
ROCE % | 35% | 7% |
Documents
Announcements
-
Closure of Trading Window
25 Sep - Trading window closed from Oct 1, 2025 until 48 hours after Q2/H1 unaudited results for period ended Sep 30, 2025.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
24 Sep - Tarsons AGM (22 Sep 2025): all nine resolutions passed; voting results and scrutinizer's report.
- Shareholder Meeting / Postal Ballot-Outcome of AGM 22 Sep
-
Reg. 34 (1) Annual Report.
18 Sep - Corrigendum: removed projected annual revenue growth 14.9% from FY2024-25 Annual Report; revised report enclosed (18 Sep 2025).
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
31 Aug - Of Newspaper Advertisement - Confirming the dissemination of Notice of 42nd Annual General Meeting and Annual Report for FY 2024-25 of the Company.
Annual reports
Concalls
-
Aug 2025Transcript PPT
-
Jun 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT REC
-
Feb 2024TranscriptNotesPPT
-
Dec 2023TranscriptPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
India’s Leading Labware Company[1]
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments)